Investing.com - GlaxoSmithKline reported on Wednesday second quarter earnings that beat analysts' forecasts and revenue that topped expectations.
GlaxoSmithKline announced earnings per share of £0.281 on revenue of £8.09B. Analysts polled by Investing.com anticipated EPS of £0.1982 on revenue of £7.6B.
GlaxoSmithKline shares are up 12% from the beginning of the year and are trading at £1,401.80 , down-from-52-week-high.They are under-performing the OMX Helsinki 25 which is up 22.26% from the start of the year.
GlaxoSmithKline shares gained 0.19% in intra-day trade following the report.
GlaxoSmithKline follows other major Healthcare sector earnings this month
GlaxoSmithKline's report follows an earnings beat by ReNeuron on Thursday, July 8, 2021, who reported EPS of £-0.09 on revenue of £216.0K, compared to forecasts EPS of £-12.70 on revenue of £1.00M.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar